LIVN News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

LI

Mkt Cap

$4.27B

Volume

634.66K

Next Earnings

November 4th

Loading chart

LI

LIVNLivaNova PLC Ordinary Shares

LIVN

Pay with—

Available Balance0.00

LI

Mkt Cap

$4.27B

Volume

634.66K

Next Earnings

November 4th

Chart Financials Earnings News About Insider Filings

Global Bioelectronic Medicine Market Anticipates Impressive Growth Trajectory of ~10% by 2034 | DelveInsightThe global bioelectronic medicine market is projected to grow from USD 8.9 billion in 2025 to USD 21.6 billion by 2034, driven by increasing adoption of neuromodulation technologies, advances in implantable devices, AI integration, and expanding applications beyond neurological disorders. North America leads the market with 44% share, while Asia-Pacific is expected to record the fastest growth rate.GlobeNewswire Inc. · Oct 6, 2026

Brain Implants Market Size to Reach USD 18.39 Billion by 2035, Growing at 9.99% CAGR | SNS InsiderThe global brain implants market, valued at USD 7.10 billion in 2025, is projected to reach USD 18.39 billion by 2035, growing at a CAGR of 9.99%. Growth is driven by rising prevalence of neurological disorders and increasing adoption of deep brain stimulation, neuromodulation systems, and brain-computer interfaces. North America leads the market, with the U.S. expected to grow from USD 3.16 billion to USD 8.17 billion by 2035.GlobeNewswire Inc. · Jun 27, 2026

Global Perfusion Systems Market to Register Incremental Growth at a CAGR of ~5% by 2034 | DelveInsightThe global perfusion systems market is projected to grow from USD 1.5 billion in 2025 to USD 2.4 billion by 2034 at a CAGR of ~5%, driven by increasing cardiovascular disorders, rising organ transplantation procedures, technological innovations, and an aging population. North America leads the market with 41% share. Recent FDA clearances for advanced perfusion devices signal continued innovation in the sector.GlobeNewswire Inc. · Apr 23, 2026

MedTech's Edge: How AI and Remote Diagnostics Drive Scalable ValueThe healthcare sector is shifting toward outpatient clinics and ambulatory services, with AI-powered diagnostics and remote care technologies gaining significant traction. Multiple medtech companies are advancing innovative solutions: VentriPoint Diagnostics is expanding cardiac imaging to remote communities via partnership with First Light Health; Senseonics demonstrated strong real-world data for its year-long continuous glucose monitor; Microbot Medical achieved clinical milestones with its robotic endovascular system; LivaNova received FDA approval for its sleep apnea treatment device; and Clover Health showed AI-assisted primary care reduces hospitalizations in high-risk patients.Benzinga · Mar 27, 2026

Global Neuromodulation Devices Market Anticipating Remarkable Growth at a CAGR of ~9% by 2032 | DelveInsightThe global neuromodulation devices market is projected to grow from USD 7.8 billion in 2024 to USD 16.1 billion by 2032, driven by increasing prevalence of chronic neurological conditions, technological innovations, and supportive regulatory frameworks. North America leads with 55% market share, while Asia-Pacific emerges as the fastest-growing region with over 12% CAGR. Recent FDA approvals include ProlivRx for depression treatment and Medtronic's adaptive deep brain stimulation system for Parkinson's disease.GlobeNewswire Inc. · Feb 23, 2026

From Humanoid Robots to AI Seating: VivaNova Debuts "Active Health" Tech at imm cologne 2026VivaNova, backed by Lumos Robotics, officially launched its Viva Series of active ergonomic chairs at imm cologne 2026 and announced the Nova Series—the world's first AI-powered smart chair coming in June 2026. The brand integrates humanoid robot technology into furniture, featuring intelligent motion systems, sensory capabilities, and adaptive support designed to provide proactive health care rather than passive support.GlobeNewswire Inc. · Jan 26, 2026

Extracorporeal Membrane Oxygenation Machine Market Size to Hit USD 725.99 Million by 2033, Growing at a CAGR of 4.91% - SNS InsiderThe global ECMO machine market is projected to grow from USD 495 million in 2025 to USD 725.99 million by 2033 at a CAGR of 4.91%, driven by rising respiratory and cardiac conditions and expanding critical care infrastructure. However, high costs, complex operations, and regulatory challenges pose barriers to market expansion. North America leads with 44.17% market share, while Asia Pacific is the fastest-growing region.GlobeNewswire Inc. · Jan 13, 2026

Global Magnetic Ablation Catheters Market Poised for Significant Growth, Projected to Reach USD 1,114.4 Million by 2035 Driven by Technological Advancements and Rising Cardiovascular Cases | Future Market Insights, Inc.The global magnetic ablation catheters market is expected to grow significantly, reaching $1.1 billion by 2035, driven by advancements in technology and the rising prevalence of cardiovascular diseases. Key factors driving growth include the increasing adoption of minimally invasive procedures and continued investment in healthcare infrastructure and R&D.GlobeNewswire Inc. · Feb 20, 2025

Cardiac Resynchronization Therapy (CRT) Market Insights, Competitive Landscape and Market Forecast 2024-2030The cardiac resynchronization therapy market is expected to grow at a CAGR of 6.49% from 2024 to 2030, driven by increasing cardiovascular disorders, innovative product developments, and the rising geriatric population. North America is expected to dominate the market during the forecast period.GlobeNewswire Inc. · Dec 9, 2024

Blood Recovery Machine Market is expected to reach revenue of USD 4,277.4 Mn by 2033, at 5.9% CAGR: Dimension Market Research.The global blood recovery machine market is expected to grow at a CAGR of 5.9% from 2024 to 2033, driven by advancements in medical technologies, increased awareness of autologous blood transfusion benefits, and rising demand for surgical procedures.GlobeNewswire Inc. · Nov 11, 2024

to start trading

LI

LIVNLivaNova PLC Ordinary Shares

LIVN

Pay with—

Available Balance0.00

Your PositionYou don't own any LIVN yet.

Related Tickers

Earnings